Base plus 3 1-year option years for radiopharmaceutical pylarify.
Ended Awarded Last action
- Contract number
- 36C25225F0092
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,784,699
Award facts
- Contract value 37% obligated
-
- $1,784,698.96 Current, with exercised options
- $4,773,892.96 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bedford, MA 01730, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $79,392 | |
| Other Administrative Action | -$193,262 | |
| Exercise an Option | $996,398 | |
| Original award | $902,171 |
About this award
Veterans Integrated Service Network 12 issued a $4.77 million firm fixed-price delivery order to Progenics Pharmaceuticals Inc. on May 1, 2025, for supply of PYLARIFY (piflufolastat F-18) radiopharmaceutical with a base period plus three one-year option years and ultimate completion date of April 30, 2026.
The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a GSA-administered multiple-award vehicle. Place of performance is Bedford, MA. PYLARIFY is a radioactive diagnostic imaging agent used in positron emission tomography scans for detection and localization of prostate cancer in federal healthcare settings serving veterans. Progenics Pharmaceuticals operates as a division of Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc.
Quick answers
Who was awarded contract 36C25225F0092?
36C25225F0092 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on May 1, 2025.
How much is contract 36C25225F0092 worth?
The government has obligated $1,784,699 on 36C25225F0092. Its potential value, with all options, is $4,773,893.
Is contract 36C25225F0092 an order under another contract?
Yes. 36C25225F0092 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25225F0092 competed?
The extent of competition for 36C25225F0092 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award